GLP-1 Receptor Agonists for Type 2 Diabetes, Obesity & Beyond
Key learning points:
- Mode of action and use in T2D & obesity
- Adverse effects and managing gastrointestinal side-effects
- GLP-1 RAs & early worsening of diabetic retinopathy
- Cardiorenal & other benefits of GLP-1 RAs
Chairperson
Speakers